Benjamin Richard J 4

What Happened

• Benjamin Richard J, Chief Medical Officer of Cerus Corp (CERS), sold 101,740 shares in an open-market transaction on March 12, 2026. The weighted-average price was $1.66 per share for total gross proceeds of approximately $168,604. This was a sale (not a purchase).

Key Details

• Transaction date: 2026-03-12 (reported on Form 4 filed 2026-03-16; filing appears timely).
• Transaction type: Sale (code S) via open market; weighted-average price $1.66; prices ranged $1.62–$1.73 per share. The reporting person will provide a breakdown of how many shares sold at each price upon request (per footnote).
• Reason/footnotes: Sale was made pursuant to an instruction elected under a Rule 10b5-1 plan to cover statutory tax withholding obligations and related brokerage fees in connection with the vesting of restricted stock units (RSUs). Footnote clarifies this was not a discretionary, market-timing sale by the insider.
• Shares owned after the transaction: Not stated in the provided filing.

Context

• This sale was executed under a pre-established 10b5-1 plan to satisfy tax withholding on vested RSUs, which is a common, routine insider action and not necessarily a signal about company prospects. Retail investors typically weigh purchases more heavily than routine withholding sales when assessing insider sentiment.